Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.
The safety and immunogenicity of a high molecular weight polysaccharide from immunotype 1 Pseudomonas aeruginosa were tested in a dose response fashion in adult volunteers. The vaccine lacked toxicity and pyrogenicity for experimental animals. Doses of 50, 75, 150, or 250 microgram were given to gro...
Salvato in:
| Pubblicato in: | J Clin Invest |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Clinical Investigation
1982
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370979/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6799548/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110453 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|